Background Clinical pharmacy services have potential to contribute significantly to the
multidisciplinary team providing safe, effective and economic care for patients. Given recent …

Introduction Globally, chronic kidney disease (CKD) is one of the leading causes of mortality.
Impaired renal function makes CKD patients vulnerable to drug-related problems (DRPs) …

Background. There is an alarming rise of chronic kidney disease prevalence globally
associated with significant morbidity and mortality necessitating special attention as one of …

Introduction: Drug-related problems can affect the treatment outcomes of hospitalized
patients and outpatients that lead to morbidity and mortality. Despite this, there were scanty …

Background Medication related problem (MRP) is an event occurring, as a result, the
medication therapy that actually or potentially interferes with desired health outcomes …

Background: Pharmacotherapy is important in reducing morbidity and mortality related to
cardiovascular diseases. However, these advantages are limited by drug therapy problems …

Background Chronic kidney disease (CKD) is a major public health concern due to its high
mortality risk, high hospitalization rates and cost, and low life expectancy. Thus, CKD …

Background Kidney dysfunction is a common, progressive condition that is increasingly
becoming a global public health issue. Because the kidneys are the major route for drug …

Background Drug therapy problems (DTPs) are common among patients suffering from
chronic kidney disease (CKD). However, there is a lack of information about DTPs and its …

Background Unresolved drug therapy-related problems (DTRPs) have economic and
clinical consequences and are common causes of patients' morbidity and mortality. This …